The Diagnostic and Predictive Value of Plasma Cystatin C in Acute Kidney Injury Secondary to Sepsis in The Intensive Care Unit
Introduction: Plasma Cystatin C (pCysC) is one of the functional biomarker for AKI. This study evaluates the utility of pCysC in diagnosing AKI, predicting death and its correlation with eGFR in septic critically ill patients. Materials and Methods: This is a two centre, prospective observational study of septic critically ill patients. The inclusion criteria were patients older than 18 years old with sepsis, SOFA score of≥2 and procalcitonin level ≥ 0.5 ng/ml. Serum Creatinine (sCr) and pCysC were measured at 0, 4, 24, 28, 48, and 52 hours. AKI was defined based on creatinine criteria of the KDIGO guideline. Results: Seventy patients were recruited into this study, of which 32 (45.7%) had AKI and 15 (21.4%) died. pCysC diagnosed AKI in all six time intervals with AUC of 0.859, 0.858, 0.876, 0.918, 0.887, and 0.879 for 0 hour, 4, 24, 28, 48, and 52 hours, respectively (p <0.0001). It did not predict death at any time interval, with an AUC range of 0.053 to 0.608 (p>0.1). pCysC showed strong negative correlation with all estimates of GFR, with the best profile recorded at 28 hours. Correlation coefficient for eGFRCG, eGFRMDRD, eGFRCKD-EPI and keGFR were -0.778, -0.763, -0.808, and -0.781, respectively (p <0.0001). There is no correlation between cardiac output and pCysC, and eGFR. Correlation coefficient were between -0.208 to 0.267 (p >0.1). Conclusion: pCysC diagnosed AKI in septic critically ill patients and strongly correlated with all estimates of GFR. However, pCysC did not predict death, nor correlate with cardiac output.
How to Cite
All material submitted for publication is assumed to be submitted exclusively to the IIUM Medical Journal Malaysia (IMJM) unless the contrary is stated. Manuscript decisions are based on a double-blinded peer review process. The Editor retains the right to determine the style and if necessary, edit and shorten any material accepted for publication.
IMJM retain copyright to all the articles published in the journal. All final ‘proof’ submissions must be accompanied by a completed Copyright Assignment Form, duly signed by all authors. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.